These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23390045)

  • 21. Vada maker's dystonia - A new task-specific focal dystonia.
    Cherian A; Divya KP
    Parkinsonism Relat Disord; 2020 Aug; 77():85-86. PubMed ID: 32653841
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias.
    De Bartolo MI; Manzo N; Ferrazzano G; Baione V; Belvisi D; Fabbrini G; Berardelli A; Conte A
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Speech-induced primary lingual dystonia: a rare focal dystonia.
    Ozen B; Gunal DI; Turkmen C; Agan K; Elmaci NT
    Neurol Sci; 2011 Feb; 32(1):155-7. PubMed ID: 20652611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin in a task-specific oromandibular dystonia in a bingo caller.
    Díaz-Sánchez M; Martínez-Castrillo JC
    J Neurol; 2008 Jun; 255(6):942-3. PubMed ID: 18481036
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®).
    Kamm C; Schümann F; Mix E; Benecke R
    J Neurol Sci; 2015 Mar; 350(1-2):110-1. PubMed ID: 25656102
    [No Abstract]   [Full Text] [Related]  

  • 28. [Levodopa-responsive dystonia: Segawa's disease. Report of a case with late onset].
    Moya-Jiménez MC; Rubí-Callejón J; Fernández-López M; Perea-Rodriguez A; Perea-Rodriguez C; Aparicio-Martinez MJ
    Rev Neurol; 2014 Dec; 59(12):571-2. PubMed ID: 25501456
    [No Abstract]   [Full Text] [Related]  

  • 29. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
    Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
    [No Abstract]   [Full Text] [Related]  

  • 30. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
    Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
    Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult-onset idiopathic lower-extremity dystonia: A rare task-specific dystonia.
    Stan A; Gherghel N; Muresanu DF
    Clin Neurol Neurosurg; 2020 Nov; 198():106106. PubMed ID: 32763664
    [No Abstract]   [Full Text] [Related]  

  • 32. Respiratory disorders associated with dystonia.
    Mehanna R; Jankovic J
    Mov Disord; 2012 Dec; 27(14):1816-9. PubMed ID: 23208724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome.
    Dressler D; Wittstock M; Benecke R
    Eur Neurol; 2001; 45(4):287-8. PubMed ID: 11385272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystonia.
    Balint B; Mencacci NE; Valente EM; Pisani A; Rothwell J; Jankovic J; Vidailhet M; Bhatia KP
    Nat Rev Dis Primers; 2018 Sep; 4(1):25. PubMed ID: 30237473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin.
    Romano M; Bagnato S; Altavista MC; Avanzino L; Belvisi D; Bologna M; Bono F; Carecchio M; Castagna A; Ceravolo R; Conte A; Cosentino G; Eleopra R; Ercoli T; Esposito M; Fabbrini G; Ferrazzano G; Lalli S; Mascia MM; Osio M; Pellicciari R; Petrucci S; Valente EM; Valentino F; Zappia M; Zibetti M; Girlanda P; Tinazzi M; Defazio G; Berardelli A
    Neurol Sci; 2022 Dec; 43(12):6929-6945. PubMed ID: 36190683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidisciplinary management of a partially edentulous patient with oromandibular dystonia: A clinical report.
    Sakar O; Matur Z; Mumcu Z; Sesen P; Oge E
    J Prosthet Dent; 2018 Aug; 120(2):173-176. PubMed ID: 29429838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dystonia: medical therapy and botulinum toxin.
    Jankovic J
    Adv Neurol; 2004; 94():275-86. PubMed ID: 14509685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.